Clinical trial Recruiting at 4 sites Interventional Ages 18 and up

Adaptive DBS for Parkinson's disease

Official title: Adaptive vs Conventional Deep Brain Stimulation for Parkinson's Disease: A Multi-center Randomized Controlled Trial

Run by Beijing Pins Medical Co., Ltd · NCT07635823 · Data updated 2026-11-12

This study tests an adaptive, closed-loop deep brain stimulation system to see if it can better control Parkinson’s symptoms and improve quality of life compared to standard fixed stimulation in adults with Parkinson’s disease.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorBeijing Pins Medical Co., Ltd
Industry-sponsored
Locations9 sites (Hefei, Anhui and 8 other locations)
StatusRecruiting
StartedMay 16, 2026
Main results expectedMay 31, 2027
Study endsSeptember 30, 2027
Registry record updatedJune 22, 2026
Trial IDNCT07635823 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with idiopathic Parkinson’s disease, HY 2.5–4 off medication, who are DBS candidates (bilateral STN or GPi) or who have had prior DBS with one IPG and are eligible for device replacement to the G1010R system.

Probably not a fit

Patients unable to undergo DBS surgery or with significant cognitive or medical contraindications may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, randomized, double‑blind crossover study compares an adaptive closed-loop DBS system (aDBS) using real-time brain signals and sleep data to conventional open-loop DBS in people with Parkinson’s disease. Participants will receive a PINS Medical G1010R neurostimulator implant and experience both stimulation modes in alternating phases. Outcomes include dyskinesia duration, off time, motor symptoms, sleep quality, and overall quality of life, with safety monitoring throughout. The trial comprises screening, surgery, DBS optimization for both modalities, crossover evaluation, and long‑term follow-up across multiple visits.

Why it matters

Potential benefit: If successful, the adaptive DBS approach could reduce troublesome dyskinesia and improve daily functioning and sleep for people with Parkinson’s disease.

How similar studies have gone: Previous DBS trials show benefit from closed-loop concepts in movement disorders, but this adaptive approach with real-time brain signal feedback is an innovative, relatively novel strategy in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* idiopathic Parkinson's disease
* Hoehn \& Yahr (HY) stage 2.5-4 during medication "OFF"
* Subjects must meet one of the following:

  1. Never underwent DBS surgery and suitable for bilateral STN or GPi DBS surgery;
  2. Previous bilateral STN/GPi DBS recipients with only one IPG who:
* Demonstrate responsiveness to conventional cDBS therapy per investigator evaluation,
* Consent to device replacement with G1010R DBS system.
* Willing and physically/mentally able to complete all study visits and procedures
* Capable of comprehending and providing written informed consent

Exclusion Criteria:

* Presence of contraindications to deep brain stimulation (DBS) surgery.
* Beck Depression Inventory-II (BDI-II) score \> 25
* Mini-Mental State Examination (MMSE) score \< 24 (adjusted for educational level)
* Significant comorbidities that may interfere with DBS therapy per investigator assessment.
* Pre-existing active non-DBS medical implants or metallic cranial implants
* Requirement for diathermy, transcranial magnetic stimulation (TMS), or electroconvulsive therapy (ECT) during the study period
* History of ablative neurosurgery or stem cell therapy for Parkinson's disease
* Inability to complete ≥3 consecutive days of comprehensive motor/sleep diaries
* Inability to maintain prescribed medication regimens or comply with protocol requirements
* Current pregnancy, lactation, or planned pregnancy during the study period
* Other conditions deemed by investigators to compromise study suitability
* Participation in other interventional clinical trials within 4 weeks prior to consent

Where it's running

  • Beijing Tiantan Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting
  • Xuanwu Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting
  • Xiangya Hospital of Central South University
    Changsha, Hunan, China
    Recruiting
  • Nanjing Brain Hospital
    Nanjing, Jiangsu, China
    Recruiting
  • The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
    Hefei, Anhui, China
    Not yet recruiting
  • Peking Union Medical College Hospital
    Beijing, Beijing Municipality, China
    Not yet recruiting
Show 3 more locations
  • First Affiliated Hospital, Sun Yat-Sen University
    Guangzhou, Guangdong, China
    Not yet recruiting
  • Qilu Hospital of Shandong University
    Jinan, Shandong, China
    Not yet recruiting
  • West China Hospital
    Chengdu, Sichuan, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.